AI PRICE FORECAST
CI Stock Forecast & AI Price Prediction
The Cigna Group · Healthcare · Healthcare Plans
CI live signal snapshot
CI last traded at $301.45, down 0.55% on the session, trading 5.2% below its 52-week high of $318.05 and 16.9% above its 52-week low of $257.85. Our AI model's current call on CI is HOLD, with 72% confidence. The technical signals aren't aligned enough for a directional call yet. Short-term moving averages are mixed right now, without a clean bullish or bearish stack forming yet. The model's one-month path points toward roughly $302.72 (0.4% from here).
On the 14-day relative strength index, CI reads 44.7, drifting toward the 30 line that marks oversold conditions. Its MACD line is below its signal line with a negative histogram (-0.79) — downward momentum is accelerating. The 50-day moving average ($287.06) sits 1.6% above the 200-day ($282.57) — a "golden cross" structure that typically supports the longer-term uptrend.
The average 12-month target from 25 Wall Street analysts is $343.08 (range $288.00–$400.00) — 13.8% upside from where CI trades now. The current recommendation trend leans bullish: 17 Buy/Strong Buy ratings vs 0 Sell/Strong Sell (and 8 Hold).
Live figures from real market data feeds, current as of the last site build. Open the interactive CI dashboard for numbers updated throughout today's session.
About The Cigna Group
The Cigna Group (CI) is a healthcare plans company in the healthcare sector, headquartered in Bloomfield, CT, United States. The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It has a market value of about $79.4 billion and roughly 65,669 full-time employees. With a beta of 0.25, the stock has historically moved less than the overall market.
CI performance vs. the market
CI is up 9.5% so far in 2026, behind the S&P 500 (+11.4%) and behind the healthcare sector fund XLV (+22.1%). On a one-year view it is up 16.8%, 5.3 points better than the S&P 500. The last month (+6.7%) continues the three-month advance (+8.4%).
| Period | CI | Sector (XLV) | S&P 500 |
|---|---|---|---|
| 1 month | +6.7% | +11.4% | −2.3% |
| 3 months | +8.4% | +12.2% | −2.3% |
| Year to date | +9.5% | +22.1% | +11.4% |
| 1 year | +16.8% | +28.3% | +11.5% |
The Cigna Group financials at a glance
In the quarter ended Sep 30, 2026, The Cigna Group reported revenue of $73.7 billion and net income of $1.4 billion (a 2.0% net margin). Revenue was up 5.6% from the same quarter a year earlier. The stock trades at a price-to-earnings ratio of 13.3 on trailing earnings of $22.68 per share. Trailing free cash flow was $8.2 billion, and total debt equals 71% of shareholders' equity.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Sep 30, 2026 | $73.7B | $1.4B |
| Jun 30, 2026 | $71.7B | $1.7B |
| Mar 31, 2026 | $68.5B | $1.7B |
| Dec 31, 2025 | $72.5B | $1.2B |
CI vs. its peers
Against 5 of its largest healthcare peers, CI's +9.5% year-to-date return beats 0 of them. The strongest of the group this year is Humana (HUM, +74.3%).
| Company | Price | YTD | P/E | AI verdict |
|---|---|---|---|---|
| The Cigna Group (CI) | $301.45 | +9.5% | 13.3 | HOLD |
| UnitedHealth Group (UNH) | $402.94 | +22.1% | 23.0 | HOLD |
| CVS Health (CVS) | $89.52 | +12.8% | 10.4 | HOLD |
| Elevance Health (ELV) | $429.48 | +22.5% | 18.2 | HOLD |
| Humana (HUM) | $446.31 | +74.3% | 43.5 | BUY |
| Eli Lilly and (LLY) | $1,437.29 | +33.7% | 46.7 | BUY |
CI stock: common questions
What is the CI stock price target?
25 Wall Street analysts put the average 12-month target at $343.08, in a range of $288.00–$400.00, versus a recent price of $301.45. Stock Pulse 247's model projects about $302.72 over the next month.
Is CI a buy right now?
Our AI model currently rates CI a HOLD at 72% confidence. Among analysts, 17 rate it Buy or Strong Buy, 8 Hold and 0 Sell. Neither is personal advice — weigh them with your own research and risk tolerance.
How has CI stock performed this year?
CI is up 9.5% so far in 2026, behind the S&P 500 (+11.4%) and behind the healthcare sector fund XLV (+22.1%). On a one-year view it is up 16.8%, 5.3 points better than the S&P 500. The last month (+6.7%) continues the three-month advance (+8.4%).
What is CI's 52-week high and low?
CI has traded between $257.85 and $318.05 over the past 52 weeks; at $301.45 it is 5.2% below its 52-week high of $318.05 and 16.9% above its 52-week low of $257.85.
What sector is CI in, and who are its peers?
CI is in the healthcare sector (healthcare plans). Its largest peers on Stock Pulse 247 include UnitedHealth Group (UNH), CVS Health (CVS), Elevance Health (ELV), Humana (HUM).
How accurate is the CI forecast?
It's a model estimate from price history, technical indicators and analyst targets, not a guarantee — no model predicts short-term moves reliably. Use it as one input alongside your own research.
How this works: the forecast combines CI's price history, momentum indicators (RSI, MACD, moving averages), volatility and analyst targets into one estimate. It's a model, not a guarantee.